StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright raised their target price on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research report on Thursday, December 12th.
Get Our Latest Research Report on SNES
SenesTech Stock Performance
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- Dividend Capture Strategy: What You Need to Know
- SAP’s Strong Momentum: A Bullish Setup for Investors
- What Investors Need to Know to Beat the Market
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- The Most Important Warren Buffett Stock for Investors: His Own
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.